An atlas of prostatic diseases /

Saved in:
Bibliographic Details
Author / Creator:Kirby, R. S. (Roger S.)
Imprint:New York : Parthenon Pub. Group, c1997.
Description:96 p.: ill. (some col.) ; 31 cm.
Language:English
Series:The Encyclopedia of visual medicine series
Encyclopedia of visual medicine series.
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/3787893
Hidden Bibliographic Details
Varying Form of Title:Prostatic diseases
ISBN:1850707642
Notes:Includes bibliographical references (p. 25-27) and index.
Table of Contents:
  • Preface
  • 1.. Introduction
  • 2.. Anatomy and embryology
  • Embryological development of the prostate
  • Anatomy of the prostatic ducts
  • Stromal-to-epithelial ratios
  • 3.. Innervation of the prostate
  • 4.. Ejaculatory function
  • 5.. Molecular mechanisms underlying prostate growth
  • 6.. Adrenoceptor signal transduction
  • 7.. Causes of abnormal prostate cell growth
  • Oncogenes
  • Tumor suppressor genes
  • 8.. Local growth potential versus metastatic capacity
  • Angiogenesis factors
  • 9.. Stepwise induction of prostatic neoplasia
  • 10.. Inflammatory processes and the prostate
  • 11.. Pathology of the prostate
  • Benign prostatic hyperplasia
  • Prostate cancer
  • Histology of prostate metastases
  • Histology of prostatitis
  • 12.. Bladder outlet obstruction
  • 13.. Progressive development of benign prostatic hyperplasia
  • 14.. Localized progression of prostate cancer
  • 15.. Metastatic spread of prostate cancer
  • 16.. Acute and chronic prostatitis
  • 17.. Diagnosis of prostatic diseases
  • History
  • Physical examination
  • Microscopy and culture of urine, and expressed prostatic secretions
  • Serology
  • Imaging studies and urinary flow rate determination
  • Transabdominal ultrasound imaging
  • Uroflowmetry
  • Pressure-flow urodynamics
  • Transrectal ultrasound imaging
  • Computed tomography and magnetic resonance imaging
  • Radionuclide bone scanning
  • 18.. Treatment options
  • Benign prostatic hyperplasia
  • Prostate cancer
  • Chemoprevention
  • Early disease
  • Antiandrogen monotherapy for those considered at high risk of recurrence
  • Management of local recurrence
  • Advanced disease and the role of LHRH analogs
  • Hormone-independent prostate cancer
  • Prostatitis
  • Sexual function and the prostate
  • 19.. Concluding perspectives
  • References
  • Index